» Articles » PMID: 6538004

Myasthenia Gravis: Prolonged Treatment with Steroids

Overview
Journal Neurology
Specialty Neurology
Date 1984 Feb 1
PMID 6538004
Citations 33
Authors
Affiliations
Soon will be listed here.
Abstract

We have evaluated chronic corticosteroid treatment in 60 myasthenic patients; 92% were followed for more than 3 years and 82% longer than 4 years. Improvement was noted in 72% of the patients. The best results were seen in those whose symptoms started after the age of 40 years. There was a correlation between the starting dose of prednisone and the rate of improvement. Complete withdrawal of steroids was possible only for 3 patients.

Citing Articles

A Rare Case of Overlapping Durvalumab-induced Myositis, Takotsubo-like Morphological Changes Caused by Myocarditis, and Myasthenia Gravis.

Saito S, Hontsu S, Hiraoka J, Yamanaka A, Fujioka N, Shimada D Intern Med. 2024; 63(23):3209-3215.

PMID: 38658343 PMC: 11671183. DOI: 10.2169/internalmedicine.3028-23.


Effectiveness of early glucocorticoids in myasthenia gravis: a retrospective cohort study.

Zhen L, Zhao X, Li W, Wu J, Shang H, Chen S Front Neurol. 2024; 14:1259484.

PMID: 38187148 PMC: 10770254. DOI: 10.3389/fneur.2023.1259484.


Pharmacotherapy of Generalized Myasthenia Gravis with Special Emphasis on Newer Biologicals.

Menon D, Bril V Drugs. 2022; 82(8):865-887.

PMID: 35639288 PMC: 9152838. DOI: 10.1007/s40265-022-01726-y.


Current Treatment of Myasthenia Gravis.

Alhaidar M, Abumurad S, Soliven B, Rezania K J Clin Med. 2022; 11(6).

PMID: 35329925 PMC: 8950430. DOI: 10.3390/jcm11061597.


Adverse Side Effects Associated with Corticosteroid Therapy: A Study in 39 Patients with Generalized Myasthenia Gravis.

Johnson S, Katyal N, Narula N, Govindarajan R Med Sci Monit. 2021; 27:e933296.

PMID: 34707081 PMC: 8562011. DOI: 10.12659/MSM.933296.